We are live on ! Find out more
ONC

BeOne Medicines Ltd
ONC

208 hedge funds and large institutions have $8.4B invested in BeOne Medicines Ltd in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 64 increasing their positions, 69 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.25% more ownership

Funds ownership: 3.52% → 3.77% (+0.25%)

7% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 69

5% less funds holding

Funds holding: 219 → 208 (-11)

18% less capital invested

Capital invested by funds: $10.3B → $8.4B (-$1.9B)

27% less funds holding in top 10

Funds holding in top 10: 11 → 8 (-3)

29% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 38

64% less call options, than puts

Call options by funds: $10.8M | Put options by funds: $29.9M

Holders
208
Holders Change
-11
Holders Change %
-5.02%
% of All Funds
3.27%
Holding in Top 10
8
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-27.27%
% of All Funds
0.13%
New
27
Increased
64
Reduced
69
Closed
38
Calls
$10.8M
Puts
$29.9M
Net Calls
-$19.1M
Net Calls Change
-$38.7M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$163M
2
BlackRock
BlackRock
New York
+$37.5M
3
UBS Group
UBS Group
Switzerland
+$12.4M
4
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
+$12.2M
5
Temasek Holdings
Temasek Holdings
Singapore
+$9.59M

Top Sellers

1
HA
HHLR Advisors
Cayman Islands
-$68M
2
Capital International Investors
Capital International Investors
California
-$62.2M
3
State Street
State Street
Massachusetts
-$59.1M
4
FFM
Fairmount Funds Management
Pennsylvania
-$51.6M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$50M
Name Holding Trade Value Shares
Change 		Change in
Stake
AAP
201
Arax Advisory Partners
Colorado
$892 – – –
BIA
202
Bell Investment Advisors
California
$535 -$461 -2 -40%
GI
203
Gradient Investments
Minnesota
$535 +$691 +3 New
CFGS
204
Concourse Financial Group Securities
Alabama
$534 +$691 +3 New
FGAM
205
Financial Gravity Asset Management
Texas
$184 +$41K +178 New
AWM
206
Abound Wealth Management
Tennessee
$179 +$230 +1 New
HNB
207
Huntington National Bank
Ohio
$178 – – –
Kayne Anderson Rudnick Investment Management
208
Kayne Anderson Rudnick Investment Management
California
$178 – – –
FFM
209
Fairmount Funds Management
Pennsylvania
– -$51.6M -239,443 Closed
CSS
210
Cubist Systematic Strategies
Connecticut
– -$3.9M -18,079 Closed
UPC
211
Utah Peaks Capital
Utah
– -$3.3M -15,300 Closed
Artisan Partners
212
Artisan Partners
Wisconsin
– -$2.84M -13,186 Closed
DZ Bank
213
DZ Bank
Germany
– -$2.51M -11,640 Closed
Mirae Asset Global Investments
214
Mirae Asset Global Investments
South Korea
– -$2.41M -11,166 Closed
CFM
215
Capricorn Fund Managers
United Kingdom
– -$1.53M -7,102 Closed
CS
216
Candriam SCA
Luxembourg
– -$1.2M -6,033 Closed
TC
217
TwinBeech Capital
New York
– -$1.15M -5,347 Closed
SH
218
SeaTown Holdings
Singapore
– -$1.08M -5,000 Closed
SAM
219
Shell Asset Management
Netherlands
– -$1M -4,658 Closed
VIA
220
Vident Investment Advisory
Georgia
– -$994K -4,613 Closed
QI
221
Qtron Investments
Massachusetts
– -$863K -4,003 Closed
AIM
222
Aigen Investment Management
New York
– -$503K -2,335 Closed
TI
223
Trexquant Investment
Connecticut
– -$374K -1,736 Closed
APG Asset Management
224
APG Asset Management
Netherlands
– -$258K -1,300 Closed
QT
225
Quantbot Technologies
New York
– -$280K -1,300 Closed
6 7 8
9
10

ONC Hedge Fund Activity: Q2 2023 in Review

208 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q2 2023, worth a combined $8.4B — down 18% from $10.3B a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of ONC and 27 opened new positions — a net loss of 11 holders — while 69 trimmed existing stakes and 64 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $163M. The largest seller was HHLR Advisors, cutting an estimated $68M.

  • 208 institutional investors held BeOne Medicines Ltd (ONC) as of Q2 2023, down from 219 in Q1 2023.
  • Funds reported $8.4B of BeOne Medicines Ltd stock for Q2 2023, down 18% quarter-over-quarter.
  • 27 funds opened new BeOne Medicines Ltd positions in Q2 2023 and 38 closed out, a net change of -11 holders.
  • The largest BeOne Medicines Ltd buyer in Q2 2023 was T. Rowe Price Associates, an estimated $163M added.
  • The largest BeOne Medicines Ltd seller in Q2 2023 was HHLR Advisors, an estimated $68M sold.

Based on aggregated 13F filings for Q2 2023.